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Abstract
Background: Depression is a common co-morbid health problem in patients with diabetes that is
underrecognised. Current international guidelines recommend screening for depression in patients with diabetes.
Yet, few depression screening instruments have been validated for use in this particular group of patients. Aim of
the present study was to investigate the psychometric properties of the Turkish version of the Centre for
Epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes.
Methods: A sample of 151 Turkish outpatients with type 2 diabetes completed the CES-D, the World Health
Organization-Five Well-Being Index (WHO-5), and the Problem Areas in Diabetes scale (PAID). Explanatory factor
analyses, various correlations and Cronbach’s alpha were investigated to test the validity and reliability of the CES-D
in Turkish diabetes outpatients.
Results: The original four-factor structure proposed by Radloff was not confirmed. Explanatory factor analyses
revealed a two-factor structure representing two subscales: (1) depressed mood combined with somatic symptoms
of depression and (2) positive affect. However, one item showed insufficient factor loadings. Cronbach’s alpha of
the total score was high (0.88), as were split-half coefficients (0.77-0.90). The correlation of the CES-D with the
WHO-5 was the strongest (r = -0.70), and supported concurrent validity.
Conclusion: The CES-D appears to be a valid measure for the assessment of depression in Turkish diabetes
patients. Future studies should investigate its sensitivity and specificity as well as test-retest reliability.
Background
Depression is a common complication of type 2 diabetes,
affecting 10-20% of the patients, particularly those with
cardiovascular complications [1,2]. A recent multi-center
study in three Dutch outpatient clinics showed that
approximately 40% of outpatients with type 2 diabetes
report depressive affect on the WHO-5 and/or the CES-
D [3]. Compared to non-diabetic controls, patients with
diabetes have a 2 times higher risk being depressed [4].
Depression is a burdensome co-morbid disease in dia-
betes that is associated with impaired quality of life [4,5].
In patients with diabetes, depression is also associated
with less optimal self-care behaviors [6], impaired glycae-
mic control and a higher risk for long term complica-
tions, higher use of medical services, and higher
mortality rates [7-11]. However, recognition rates of
depression in diabetes were found to be low, for example
with medical staff recognizing 20-25% of cases [12,13].
Recently, the prevalence of diabetes in Turkey was esti-
mated at 2.9 million [14]. This would mean that approxi-
mately 290.000 to 580.000 Turkish people suffer from
both diabetes and co-morbid depression. Current guide-
lines from the International Diabetes Federation for the
treatment of type 2 diabetes recommend the routine use
of questionnaires to assess psychological wellbeing in
clinical practice [15]. One well-established questionnaire
examining depressive symptoms is the Centre for
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which could be used for this purpose. However, the psy-
chometric properties of this questionnaire have not been
examined yet in a Turkish sample of diabetic patients.
The aim of this paper is therefore to investigate several
aspects of the validity and reliability of the Turkish
version of the CES-D in patients with diabetes, including
its latent structure. We aimed to explore the latent struc-
ture of the CES-D (Turkish version) as earlier research
has described different factor structures for this scale. As
a result, it is unclear which factor structure should be
used in Turkish participants (and specifically in diabetic
Turkish patients).
Methods
Design
This paper describes posterior analyses on data from a
previous study concerning the associations between
depression and appraisal of insulin therapy [17]. The ori-
ginal study was conducted in two outpatient clinics in
Istanbul, Turkey: the Istanbul Medical Faculty Hospital
and the Cerrahpaşa Medical Faculty Hospital. Consecu-
tive patients with Type 2 diabetes mellitus who were
treated with a diet and/or oral agents were invited to par-
ticipate in this study. Exclusion criteria for the original
research were being illiterate or not being able to read
due to vision problems. All subjects gave their written
informed consent and the Ethical Review Committee of
the Istanbul University Medical Faculty and Cerrahpaşa
Medical Faculty approved the study.
Measures and Data
Demographic characteristics and data concerning treat-
ment for diabetes or depression were acquired through
self-report.
CES-D
The Centre for Epidemiologic Studies Depression Scale
(CES-D) is a self-report questionnaire that has been devel-
oped to measure depressive symptoms and to detect peo-
ple at risk of having a depressive disorder [16]. The
Turkish version of the CES-D, developed by Spijker and
colleagues [18], was used in the presented study. The
CES-D contains 20 items that can be responded to on a
four-point Likert scale, with response categories ranging
from ‘rarely or none of the time’ (0 points) to ‘most or all
of the times’ (3 points) which are summed up to a total
score where higher score indicate more severe depressive
symptoms. A cut-off score of ≥ 16 is generally accepted as
indicator for clinical meaningful depressive symptoms.
Earlier studies yielded a four-factor-structure [16] that
has been replicated in various studies [19-24]. However,
studies in more specific populations or with diverse eth-
nical backgrounds have found inconsistent results. For
example, Spijker et al. [18] reported a five-factor struc-
ture for Dutch elderly, a four-factor structure for Turk-
ish elderly, and a three-factor structure for Moroccan
elderly people living in the Netherlands while Fountou-
lakis et al. [25] reported a three-factor structure for a
Greek sample. Furthermore, Tatar and Saltukoglu [26]
conducted extensive analyses in a huge sample of 1143
Turkish students and healthy adults, supporting the
initial four-factor structure, but also reporting problems
concerning the dimension of somatic complaints and
especially with item 7. Given these findings, we antici-
pated to find a four-factor structure in our dataset.
WHO-5
The World Health Organization-Five Well-Being Index
(WHO-5, [27]) is a brief self-report measure that can be
used to assess general emotional well-being over the past
two weeks. It consists of five positively formulated items
that can be answered on a six-point Likert scale, ranging
from ‘not present’ (0) to ‘constantly present’ (5). These
scores have to be summed up to acquire the total well-
being index ranging from 0 (worst outcome) to 25 (best
outcome). A sum score of ≤ 13 was introduced as cut-off
indicating depression [28]. The WHO [29] also suggested
another way of handling the sum score. They suggested
multiplying the sum score by 4, yielding possible total
scores between 0 and 100 (best outcome) which could be
treated as percentages and percentage scores lower than
28 indicate depression. The WHO-5 appeared to be
applicable for diabetes patients [28,30] and to be one of
the most sensitive (93%) measures to detect depression,
compared to other brief self-report measures [31]. How-
ever, specificity tended to be relatively low, (64%) which
indicates that the percentage of false-positive results is
rather high. Since the WHO-5 measures a positively con-
noted construct as well-being, we suspect negative asso-
ciations with the outcome of the CES-D.
PAID
The Problem Areas in Diabetes scale (PAID) is a 20 item
self-report measurement that can be used to assess dia-
betes-specific emotional distress, such as worries about
complications or concerns about food [17,32,33]. The
items are rated on a six-point Likert-scale ranging from
‘n o tap r o b l e m ’ (1) to ‘a serious problem’ (6). The raw
scores are transformed into a scale ranging from 0 - 100
where higher scores indicate more emotional problems
related to diabetes. If problems related to diabetes coin-
cide with depressive symptoms, their association is con-
sequently suspected to be positive.
Statistical analysis
Descriptive analyses were conducted in order to
inspect sample characteristics and outcome on the
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analyses were planned (using oblique rotation) to
examine the underlying factor structure of the CES-D.
The Scree plot and eigenvalues > 1 criterion were used
to decide about the appropriateness of the number of
retrieved factors. An oblique (instead of varimax) rota-
tion was used, based on the assumption that a test
measuring depression will have correlated factors.
However, an explanatory factor analysis using an
orthogonal varimax rotation was also performed to
ensure comparability with previous validation studies.
Reliability was examined inspecting the internal consis-
tencies (Cronbach’s alpha) of the total score and sub-
scales indicated by the factor analysis. Correlations
between the CES-D with the other self-report mea-
sures were calculated, using Pearson’s correlation, to
test its convergent validity.
Results
Participants
Three participants had to be excluded from the analysis
d u et oi n c o m p l e t ed a t ao nt h eC E S - Dl e a v i n gas a m p l e
of 151 participants for analysis. Their demographic and
clinical characteristics and their mean scores on the
CES-D, WHO-5, and PAID can be seen in Table 1. On
average the sample consisted of elderly patients as it is
usual in type 2 diabetes (mean: 56 years), but it can also
be seen that several young participants (6% of the whole
sample < 40 years) were already diagnosed with type 2
diabetes. Almost a quarter (24%) of the whole sample
met the criterion for being considered depressed using
the CES-D cut-off (≥ 16) while only 12.6% would be
considered depressed according to the WHO-5 cut-off
(≤ 28).
Construct validity
The Kaiser-Meyer-Olkin test (KMO) was found to be
.891 (thus higher than .50) and Bartlett’s test of spheri-
city showed a highly significant result (c
2 = 1409.1),
thus both tests indicated the appropriateness of per-
forming factor analyses in the presented sample [34].
The explanatory factor analysis yielded a 5-factor-solu-
tion with a very large eigenvalue of 7.35 for the first fac-
tor and four more factors with eigenvalues larger than 1.
The first factor comprised 10 items that represented
symptoms related to depressed mood. The second factor
also had a relative high eigenvalue of 2.25 and clearly
comprised the items examining positive affect (items 4, 8,
12, and 16). However, this five-factor solution had to be
discarded as non-feasible since the fourth factor only
Table 1 Demographic, clinical and psychological characteristics of the whole sample of type 2 diabetes participants; as
well as separated by gender and hospital where they have been treated
Whole sample Istanbul University Hospital Cerrahpaşa University Hospital
Male female male female
Patients 100% (151) 31% (46) 32% (49) 15% (23) 22% (33)
Age in years (SD);
range
56 (10)
28 - 81
56 (10)
28 - 75
55 (9)
36 - 79
60 (13)
30 - 81
56 (9)
40 - 73
BMI (SD); range 29.0 (4.5)
21 - 45
27.3 (3.4)
21 - 36
29.7 (4.6)
23 - 41
28.8 (3.9)
23 - 38
30.7 (5.7)
23 - 45
Diabetes duration
< 1 year 11% (16) 9% (4/46) 2% (1/49) 26% (6/23) 15% (5/33)
1-4 years 30% (45) 28% (13/46) 35% (17/49) 22% (5/23) 30% (10/33)
5-10 years 37% (56) 39% (18/46) 41% (20/49) 35% (8/23) 30% (10/33)
> 10 years 22% (34) 24% (11/46) 22% (11/49) 17% (4/23) 25% (8/33)
Level of education
Primary school 20% (30) 2% (1/46) 25% (12/49) 9% (2/23) 46% (15/33)
Middle school 14% (21) 15% (7/46) 6% (3/49) 13% (3/23) 24% (8/33)
College 25% (38) 35% (16/46) 25% (12/49) 30% (7/23) 9% (3/33)
University 41% (62) 48% (22/46) 44% (22/49) 48% (11/23) 21% (7/33)
CES-D; m (SD) 11 (9.7) 9.7 (7.8) 11.6 (8.9) 7.3 (8.1) 14.3 (13.0)
CES-D ≥ 16; 24% (36) 13% (6/46) 25% (12/49) 22% (5/23) 40% (13/33)
WHO-5; m (SD) 62.5 (27.4) 67.9 (26.4) 58.7 (25.9) 67.6 (25.7) 57.5 (30.8)
WHO ≤ 28, 13% (19) 11% (5/46) 14% (7/49) 4% (1/23) 18% (6/33)
PAID; m(SD) 26.8 (18.7) 28 (23) 34 (22) 30 (23) 39 (24)
PAID ≥ 40, 27% (40) 24% (11/46) 37% (18/49) 17% (4/23) 21% (7/33)
* physical complications associated with diabetes;
35 patients (23%) reported one complication; 15 (10%) reported two complications; 4 (3%) reported three complications; and 1 patient (1%) reported four
complications
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tent of the third and fifth factor were rather inconclusive
(Table 2). Subsequently, new factor analyses were per-
formed using forced entry to determine the number of
resulting factors. The scree plot actually suggested a two-
factor solution, but we continued our analyses forcing
four factors into the final model since previous studies
(e.g. [16,26]) suggested a four-factor structure. Results of
this factor analyses showed that the initial fifth factor
(subsuming three items) was split and the items were
rearranged in such way that two items (2 and 9) now
loaded on the first factor, turning it more into a scale of
depressed mood with somatic complaints. The third item
(15) was added to the third factor making it a subscale
concerning social/interactional aspects of depression.
However, item 13 formed again one separate factor
(fourth) and this solution was therefore also regarded as
not feasible. In the next step, an additional factor analysis
was conducted forcing three factors into the final model.
Finally, item 13 elapsed into the first factor not forming a
separate factor anymore, but its loading was rather lower
(0.41) compared to the others (ranging from 0.55 to
0.79). Additionally, item 2 (no appetite) appeared to have
relatively low loadings on two factors: 0.39 on the first
factor and 0.32 on the third factor. Inclusion of item 2 in
the third factor would not have turned it into a meaning-
ful scale, because the other items (1, 15, and 19) were
related to social/interpersonal aspects. Inclusion of item
2 in the first factor might be advised based on its content,
but this low loading (and especially double loading) was
not regarded as a satisfying solution. The final step was a
factor analysis, forcing a two-factor-solution (see Table
2) were finally the depressed, somatic, and socially-
related items formed one factor that could be named
“depression” and a second factor comprising “positive
affect”. However, note the very low loading of item 19
(others dislike me; 0.14).
In summary, these factor analyses showed that the
latent structure of the Turkish version of the CES-D
could best be described as a one-factor solution (given
the high first eigenvalue) or a 2-factor solution (depres-
sion and positive affect). The two factors were moder-
ately correlated with another r = .329 (p < .0001), but
strongly associated to the total score with r = .918
(depression) and r = .676 (positive affect).
To also assure comparability with the original factor
analysis performed by Radloff, we repeated the explanatory
factor analysis using varimax rotation. The same unfeasi-
ble 5-factor solution has been found, only the ordering of
the factors was different. Also, the subsequent factor
Table 2 Results from the factor analyses of the 5-factor and the 2-factor solution
5-factor-
solution
2-factor-solution
nr. description Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 1 Factor 2
7.354* 2.249* 1.325* 1.152* 1.035* 7.354* 2.249*
3 blues ,566 ,681
5 troubles focusing ,713 ,777
6 depressed ,758 ,785
7 too much effort ,626 ,775
10 fearful ,490 ,624
11 troubled sleep ,742 ,721
14 lonely ,830 ,782
17 crying ,708 ,697
18 sad ,762 ,763
20 not get going ,697 ,739
4 as good as others ,775 ,770
8 hopeful ,820 ,765
12 happy ,789 ,784
16 enjoy life ,737 ,752
1 bothered ,591 ,503
19 others dislike me ,815 ,136
13 talk less ,726 ,428
2 poor appetite ,705 ,526
9 failure ,641 ,611
15 unfriendly people ,812 ,463
* = eigenvalue
Lehmann et al. BMC Medical Research Methodology 2011, 11:109
http://www.biomedcentral.com/1471-2288/11/109
Page 4 of 7analyses using forced entry showed the same problematic
results finally suggesting the same 2-factor solution (data
not shown).
Reliability
The reliability of the CES-D was examined using Cron-
bach’s alpha of the total score which was found to be
high with 0.88. Also the split half coefficients were
found to be almost as equally high, with two alphas for
both test halves being 0.78. Moreover, the item-total
correlations were overall quite high (ranging from 0.42-
0.73) but also showed some low values of 0.12, 0.20, and
0.25 for the items 19 (others dislike me), 13 (talk less),
and 4 (as good as others) respectively (see also Table 3).
Additionally, the internal consistencies of the two
extracted factors from the final factor analysis were
investigated. The first factor (16 items), comprising
symptoms related to depressed mood with somatic com-
plaints, yielded a very high value of 0.90 and item-total-
correlations were satisfying from 0.30-0.75, yet again the
item 19 that already showed a low factor loading also
showed a very weak correlation with its scale of 0.13.
The second factor (4 items) comprising positive affect
also showed a quite high Cronbach’s alpha with a value
of 0.82 and quite high item-total correlations ranging
from 0.55 to 0.73 (see Table 3).
Convergent validity
The correlations between the CES-D (total score and
the two extracted factors) and the other self-report mea-
sures, examining convergent validity, showed highly sig-
nificant values ranging from r = 0.17-0.70. The
(negative) association of the CES-D total score with the
WHO-5 was the strongest (r = -0.70) while the associa-
tions with the PAID where somewhat lower ranging
from 0.34-0.45. The second extracted factor of the CES-
D showed the lowest association with the other measure
ranging from 0.17-0.45 (see also Table 4).
Discussion
This study was the first to investigate the psychometric
properties of the CES-D in a Turkish sample of diabetes
mellitus type 2 patients. We aimed to focus on the factor
structure, concurrent validity, and reliability of the Turk-
ish version of the CES-D. The results of our factor ana-
lyses did neither confirm the initial 4-factor structure of
the CES-D nor former findings in other countries which
showed 3-, 4-, or 5-factor solutions. In contrast, our
results showed a 2-factor solution separating depressed
mood (combined with somatic complaints) and positive
affect into two factors which were coherent in terms of
item content. However, the very large eigenvalue for the
first factor is in line with other findings supports the
usage of the CES-D as a one-dimensional measure inves-
tigating depressed mood. The fact that we found a 2-fac-
tor structure with positively and negatively worded items
is in line with results from several other self-report mea-
sures (e.g. the W-BQ12 or ITAS [35,36]) since it is com-
mon that positively and negatively worded items load on
different factors. Yet, they both contribute and form
parts of the overall construct of depression as shown by
their correlation with each other and with the total score.
Their correlations with the other self-report measures
suggest that the first factor (depression) is more strongly
associated with the other measures yielding similar
results as the total score. However, correlations of the
second factor showed to be of significant importance as
well. The usefulness of the combination of depressed and
somatic complaints in our first factor may be questioned
though. There is the well-known problem that people
with chronic diseases show elevated levels of depression
measured with self-report instrument due to somatic
complaints that are actually caused by their disease and
not depression. This is for example also the case in the
Beck Depression Inventory and a general problem in
chronically ill people and not specific to the CES-D.
Two items of the CES-D appeared to have less opti-
mal scaling characteristics in the present study: item 13
Table 3 Results of the reliability analyses using
Cronbach’s Alpha
Total scale
Alpha: .88
Factor 1
Alpha: .90
Factor 2
Alpha: .82
(1) (2) (1) (2) (1) (2)
1 .481 .487
2 .429 .469
3 .590 .621
4 .251 .89 .548 .82
5 .646 .712
6 .736 .754
7 .700 .732
8 .422 .88 .640
9 .535 .550
10 .476 .541
11 .588 .651
12 .582 .728
13 .199 .88 .301 .90
14 .624 .698
15 .480 .466
16 .537 .658
17 .561 .611
18 .647 .691
19 .117 .88 .126 .90
20 .674 .691
(1) item-total correlation
(2) Cronbach’s Alpha if item is deleted (only values are shown that increased/
yielded the same alpha value)
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formed a separate factor in our first factor analysis
(resulting in a 5-factor solution) and also in the 4-factor
solution, before elapsing into the first factor and show-
ing satisfying factor loadings in the subsequent analysis.
However, item 19 is of higher importance, because its
factor loading is rather low. We hold the opinion that
this may be due to cultural factors, as Turkey is more of
a group culture, less individualized, where the family
and family members play a relatively important role. It
may also be that the scaling characteristics will become
better in samples with more severe depression. For
example, in the present study, over 80% of the partici-
pants denied that others disliked them, therefore the
distribution of this item was rather skewed.
One could also argue that these rather unsuspected
results of the factor analyses can be attributed to the
fact that we used an oblique rotation in contrast to vari-
max which was used in former publications. However,
we also checked this technique and the results were the
same only showing a different order of the extracted
factors. Thus, our expected four-factor structure was
not supported by the data which was surprising, since
especially the findings of Tatar and Saltukoglu [26] pro-
mised similar results due to the same cultural back-
ground of the sample. However, testing a chronically ill
sample may means a higher association of depressed
and somatic symptoms leading to their combined load-
ing on one factor instead of in a healthy sample where
depressed and somatic complaints may be more fine-
grained and loose from another.
In general, different factoranalytic outcomes in differ-
ent studies seem not too problematic for clinical prac-
tice, since the use of the CES-D total score is supported
by the results of the present study.
The CES-D proved to be a highly reliable instrument
within this sample with high Cronbach’s alpha values for
the total score and the two factors ranging from 0.82 - 0.90.
The correlations of the CES-D with the WHO-5 and
t h eP A I Dw e r ei nl i n ew i t he x p e c t a t i o n s ,w ef o u n da
strong negative association between depressed mood
and emotional well-being and less strong, but positive,
associations between depressed aspects and diabetes
related problems.
A major limitation of our study was the relatively
small sample size. However, preliminary tests as KMO
and Bartlett’s test assured the appropriateness of our
sample for trustworthy factor analyses. However, future
research should also include more heterogeneous sam-
ples for example concerning the severity and treatment
of diabetes. Another limitation of our study is the fact
that the patients had no clinical diagnoses concerning
depressed mood or major depressive disorder. This
would have facilitated testing the sensitivity and specifi-
city to challenge the screening capacity of the CES-D
even more. Determining the percentage of diabetes
patients with elevated levels of depressive symptoms
within this sample yielded numbers of about one quarter
and one tenth respectively, using the cut-offs of the
CES-D and WHO-5. Our sample reported a mean
CESD score of 11 (SD = 9.7) which imposes the ques-
tion whether another cut-off for the CESD might be
more appropriate in Turkish diabetic populations. A
score higher than one standard deviation above the
mean could indicate an appropriate cut-off which would
yield a score of 21 in this sample. However, more stu-
dies also including verified diagnoses of depression, both
types of diabetes, patients from primary care settings,
and patients with more severe treatment (i.e. insulin)
should be conducted to approach the possibility of a dif-
ferent cut-off more thoroughly.
Conclusion
In conclusion, we want to highlight the overall good per-
formance of the CES-D concerning its psychometric
properties. Considering the recommendation of the
International Diabetes Federation to routinely use ques-
tionnaires assessing the psychological well-being in dia-
betes patients we assume that the CES-D can be used as
a valid and reliable measure for the assessment of depres-
sion in Turkish diabetes patients. Nevertheless, we want
to emphasize that screening only is not enough since a
high amount of false positive results are produced by
screening measures and they could never substitute a
Table 4 Pearson’s Correlations of the CES-D scores with the WHO-5 and PAID scores
CES-D CES-D Factor 1 CES-D Factor 2
(20 items) (16 items) (4 items)
WHO-5 -.70** -.65** -.45**
PAID .45** .41** .29**
diabetes-related emotional problems .43** .39** .28**
treatment-related problems .35** .35** .17*
food-related problems .36** .32** .26**
social support problems .34** .28** .30**
** p < .01; * p < .05
Lehmann et al. BMC Medical Research Methodology 2011, 11:109
http://www.biomedcentral.com/1471-2288/11/109
Page 6 of 7detailed clinical interview and diagnosis. Moreover,
screening for depression should be embedded in a colla-
borative care approach for depression [37].
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